1
TÍTULO: 187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
AUTORES: Jalid Sehouli; Ignace Vergote; Erika Hamilton; Alejandro Pérez Fidalgo; Toon Van Gorp; Giovanni Scambia; Jaroslav Klat; Tally Levy; Stephen Welch; Debra L Richardson; Eva Maria Guerra Alía; Stéphanie Henry; Pauline Wimberger; David Scott Miller ; Jerónimo Martínez; Bradley J Monk; Pratheek Kalyanapu; Monsoor Raza Mirza; Vicky Makker;
PUBLICAÇÃO: 2024, FONTE: Oral Sessions
INDEXADO EM: CrossRef: 2
2
TÍTULO: Dose-expansion part of a phase 1b global study of E7386 in combination with lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC) and other solid tumors including endometrial cancer (EC).
AUTORES: Jung-Yun Lee; Baek-Yeol Ryoo; Jin Won Kim; Ann-Lii Cheng; Richard S Finn; Kosei Hasegawa; Vicky Makker; Masatoshi Kudo; David Scott Miller ; Philippe Merle; Susanna Varkey Ulahannan; Tetsuya Hosaka; Takatoshi Sahara; Cixin S He; Karen O'Hara; Lea Dutta; Toshiyuki Tamai; Masafumi Ikeda;
PUBLICAÇÃO: 2024, FONTE: Journal of Clinical Oncology, VOLUME: 42, NÚMERO: 16_suppl
INDEXADO EM: CrossRef
3
TÍTULO: Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma
AUTORES: Daniela E Matei; Danielle M Enserro; Marcus E Randall; David Mutch; William Small; Paul A DiSilvestro; Nick M Spirtos; David M O’Malley; Guilherme H Cantuaria; David Michelin; Steven Waggoner; Mark Shahin; Saketh Guntupalli; Olivia Lara; Frederick R Ueland; David Warshal; Albert Bonebrake; Krishnansu S Tewari; Annie Tan; Matthew A Powell; Joan L Walker; Alessandro D Santin; Jong Hyeok Kim; David Scott Miller ; ...Mais
PUBLICAÇÃO: 2024, FONTE: Journal of Clinical Oncology
INDEXADO EM: CrossRef
4
TÍTULO: Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study  Full Text
AUTORES: Vicky Makker; Jose Alejandro Perez Fidalgo; Giorgio Valabrega; Erika Hamilton; Toon Van Gorp; Jalid Sehouli; Klaudia Regináčová; Debra L Richardson; Tamar Perri; Amit M Oza; David Scott Miller ; Eva Maria Guerra Alía; Ugo De Giorgi; Stephanie Henry; Daniel L Spitz; Pauline Wimberger; Markéta Bednaříková; Hye Sook Chon; Jerónimo Martínez Garcia; Carmela Pisano; Jonathan S Berek; Ignacio Romero; Giovanni Scambia; Lorena Fariñas Madrid; Joseph Buscema; Fabienne Schochter; Kai Li; Pratheek Kalyanapu; Christopher J Walker; Ignace Vergote; ...Mais
PUBLICAÇÃO: 2024, FONTE: Gynecologic Oncology, VOLUME: 185
INDEXADO EM: Scopus CrossRef: 3
5
TÍTULO: Phase 3 dose selection for selinexor in TP53wt endometrial cancer based on exposure-response analysis.
AUTORES: Vicky Makker; Debra L Richardson; Hye Sook Chon; David Scott Miller ; Morten Mau-Sørensen; David Cibula; Flora Zagouri; Alejandro Pérez Fidalgo; Brian M Slomovitz; Robert L Coleman; Pratheek Kalyanapu; Rong Fan; Girish Gudi; Ignace Vergote;
PUBLICAÇÃO: 2024, FONTE: Journal of Clinical Oncology, VOLUME: 42, NÚMERO: 16_suppl
INDEXADO EM: CrossRef
6
TÍTULO: Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279
AUTORES: Neil S Horowitz; Wei Deng; Ivy Peterson; Robert S Mannel; Spencer Thompson; Elizabeth Lokich; Tashanna Myers; Parvis Hanjani; David M O'Malley; Ki Young Chung; David Scott Miller ; Frederick R Ueland; Don S Dizon; Austin Miller; Jyoti S Mayadev; Charles A Leath; Bradley J Monk;
PUBLICAÇÃO: 2024, FONTE: Journal of Clinical Oncology, VOLUME: 42, NÚMERO: 16
INDEXADO EM: Scopus CrossRef: 1 Unpaywall
7
TÍTULO: Predicting Vte and Utility of Thromboprophylaxis in Metastatic and Recurrent Cervical Cancer
AUTORES: Christopher A Walker; Carson Edwards; Don McIntire; Lydia Makepeace; Steven B Holloway; Ev Kakadiaris; Alexandra Spirtos; David Scott Miller ; Jayanthi Lea;
PUBLICAÇÃO: 2024
INDEXADO EM: CrossRef
8
TÍTULO: Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancer  Full Text
AUTORES: Christopher A Walker; Carson Edwards; Don McIntire; Lydia Makepeace; Steven Blaine Holloway; Ev Kakadiaris; Alexandra N Spirtos; David Scott Miller ; Jayanthi S Lea;
PUBLICAÇÃO: 2024, FONTE: Gynecologic Oncology, VOLUME: 188
INDEXADO EM: Scopus CrossRef
9
TÍTULO: Radiation Therapy with or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results from an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial
AUTORES: Ann H Klopp; Danielle Enserro; Matthew Powell; Marcus Randall; Julian C Schink; Robert S Mannel; Laura Holman; David Bender; Christina L Kushnir; Floor Backes; Susan L Zweizig; Steven Waggoner; Kristin A Bradley; Lana Desouza Lawrence; Parviz Hanjani; Christopher J Darus; William Small; Higinia R Cardenes; Jonathan M Feddock; David Scott Miller ;
PUBLICAÇÃO: 2024, FONTE: Journal of Clinical Oncology, VOLUME: 42, NÚMERO: 20
INDEXADO EM: Scopus CrossRef: 3
10
TÍTULO: Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14  Full Text
AUTORES: Jubilee Brown; Austin Miller; Laura L Holman; Floor Backes; Christa Nagel; David Bender; David Scott Miller ; Matthew A Powell; Shannon N Westin; Albert Bonebrake; Carolyn Y Muller; Angeles Alvarez Secord; Erin Crane; John Schorge; William P Tew; Anil K Sood; Michael A Bookman; Carol Aghajanian; David M Gershenson;
PUBLICAÇÃO: 2024, FONTE: Gynecologic Oncology, VOLUME: 190
INDEXADO EM: Scopus CrossRef
Página 1 de 30. Total de resultados: 299.